SE9802402D0 - Method of diagnosing cardiovascular disease and early atherosclerosis - Google Patents

Method of diagnosing cardiovascular disease and early atherosclerosis

Info

Publication number
SE9802402D0
SE9802402D0 SE9802402A SE9802402A SE9802402D0 SE 9802402 D0 SE9802402 D0 SE 9802402D0 SE 9802402 A SE9802402 A SE 9802402A SE 9802402 A SE9802402 A SE 9802402A SE 9802402 D0 SE9802402 D0 SE 9802402D0
Authority
SE
Sweden
Prior art keywords
cardiovascular disease
diagnosing cardiovascular
early atherosclerosis
human
present
Prior art date
Application number
SE9802402A
Other languages
English (en)
Inventor
Johan Frostegaard
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE9802402A priority Critical patent/SE9802402D0/sv
Publication of SE9802402D0 publication Critical patent/SE9802402D0/sv
Priority to US09/720,967 priority patent/US6780605B1/en
Priority to PCT/SE1999/001208 priority patent/WO2000002046A1/en
Priority to DK99933432T priority patent/DK1095271T3/da
Priority to AU49489/99A priority patent/AU4948999A/en
Priority to ES99933432T priority patent/ES2205853T3/es
Priority to AT99933432T priority patent/ATE250228T1/de
Priority to DE69911417T priority patent/DE69911417T2/de
Priority to EP99933432A priority patent/EP1095271B1/en
Priority to US10/814,194 priority patent/US20040185515A1/en
Priority to US10/814,195 priority patent/US20040185516A1/en
Priority to US10/814,125 priority patent/US7662577B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
SE9802402A 1998-07-03 1998-07-03 Method of diagnosing cardiovascular disease and early atherosclerosis SE9802402D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9802402A SE9802402D0 (sv) 1998-07-03 1998-07-03 Method of diagnosing cardiovascular disease and early atherosclerosis
EP99933432A EP1095271B1 (en) 1998-07-03 1999-07-02 Method of diagnosing cardiovascular disease and early atherosclerosis
AU49489/99A AU4948999A (en) 1998-07-03 1999-07-02 Method of diagnosing cardiovascular disease and early atherosclerosis
PCT/SE1999/001208 WO2000002046A1 (en) 1998-07-03 1999-07-02 Method of diagnosing cardiovascular disease and early atherosclerosis
DK99933432T DK1095271T3 (da) 1998-07-03 1999-07-02 Fremgangsmåde til diagnose af hjertekar-sygdomme og tidlig aterosklerose
US09/720,967 US6780605B1 (en) 1998-07-03 1999-07-02 Method of diagnosing cardiovascular disease and early atherosclerosis
ES99933432T ES2205853T3 (es) 1998-07-03 1999-07-02 Metodo para diagnosticar la enfermedad cardiovascular y la aterosclerosis precoz.
AT99933432T ATE250228T1 (de) 1998-07-03 1999-07-02 Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose
DE69911417T DE69911417T2 (de) 1998-07-03 1999-07-02 Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose
US10/814,194 US20040185515A1 (en) 1998-07-03 2004-04-01 Method of diagnosing spontaneous abortion
US10/814,195 US20040185516A1 (en) 1998-07-03 2004-04-01 Kit for diagnosing cadiovascular disease and early atherosclerosis
US10/814,125 US7662577B2 (en) 1998-07-03 2004-04-01 Method of diagnosing cardiovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802402A SE9802402D0 (sv) 1998-07-03 1998-07-03 Method of diagnosing cardiovascular disease and early atherosclerosis

Publications (1)

Publication Number Publication Date
SE9802402D0 true SE9802402D0 (sv) 1998-07-03

Family

ID=20411962

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802402A SE9802402D0 (sv) 1998-07-03 1998-07-03 Method of diagnosing cardiovascular disease and early atherosclerosis

Country Status (2)

Country Link
US (4) US6780605B1 (sv)
SE (1) SE9802402D0 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569674B2 (en) * 1998-05-04 2009-08-04 Innexus Biotechnology International Limited Autophilic antibodies
US20040185039A1 (en) * 2002-08-30 2004-09-23 Heinz Kohler Therapeutic applications of noncovalent dimerizing antibodies
US20050033033A1 (en) * 1998-05-04 2005-02-10 Heinz Kohler Trans-membrane-antibody induced inhibition of apoptosis
US20090208418A1 (en) * 2005-04-29 2009-08-20 Innexus Biotechnology Internaltional Ltd. Superantibody synthesis and use in detection, prevention and treatment of disease
SI1735349T1 (sl) 2004-04-15 2010-12-31 Athera Biotechnologies Ab Postopek ocenitve tveganja ishemske kardiovaskularne bolezni z uporabo fosforilholinskih konjugatov
JP5645361B2 (ja) 2005-08-02 2014-12-24 エクスバイオテク インコーポレーティッド ＩＬ−１α自己抗体を用いた血管障害の診断、処置、および予防
US20110008282A1 (en) * 2006-05-15 2011-01-13 Xbiotech, Inc. IL-1alpha immunization induces autoantibodies protective against atherosclerosis
AU2007251239B2 (en) * 2006-05-15 2013-08-22 Xbiotech Inc. IL-1alpha immunization induces autoantibodies protective against atherosclerosis
ES2374845T3 (es) * 2006-05-22 2012-02-22 Xbiotech, Inc Tratamiento de cáncer con anticuerpos anti-il-1.
US7935498B2 (en) * 2006-07-07 2011-05-03 Siemens Healthcare Diagnostics Inc. Methods for identifying patients with increased risk of an adverse cardiovascular event
JP2011500868A (ja) * 2007-10-30 2011-01-06 アセラ・バイオテクノロジーズ・アーベー 心血管疾患用の診断及び治療法並びに組成物
AU2009255670B2 (en) * 2008-05-30 2011-12-15 Janssen Biotech, Inc. IL-1alpha Abs and methods of use
CA2737056C (en) * 2008-09-12 2018-10-30 Xbiotech Inc. Targeting pathogenic monocytes
PT2582391T (pt) 2010-06-18 2019-01-11 Xbiotech Inc Tratamento da artrite
KR101910760B1 (ko) 2010-08-23 2018-10-22 엑스바이오테크, 인크. 종양성 질병들에 대한 치료
US9724409B2 (en) 2011-04-01 2017-08-08 Xbiotech, Inc. Treatment of inflammatory skin disease
US9803028B2 (en) 2011-08-09 2017-10-31 Athera Biotechnologies Ab Antibodies against phosphorylcholine
AU2012294431B2 (en) 2011-08-09 2017-03-30 Athera Biotechnologies Ab Antibodies binding to phosphorylcholine (PC) and/or PC conjugates
DK2750709T3 (en) 2011-09-23 2018-12-03 Xbiotech Inc TREATMENT OF KAKEKSI
US9545441B2 (en) 2012-09-18 2017-01-17 Xbiotech, Inc. Treatment of diabetes
JP7145162B2 (ja) 2017-02-16 2022-09-30 ヤンセン バイオテク，インコーポレイテッド 化膿性汗腺炎の処置
WO2021134505A1 (zh) * 2019-12-31 2021-07-08 同济大学 一种用于预测早期流产风险的试剂盒及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
EP0299965A4 (en) * 1986-03-24 1992-12-16 University Of Sydney Antigenic analogues of platelet activating factor (paf)
US4879285A (en) * 1986-08-22 1989-11-07 Royal North Shore Hospital And Area Health Service Fertility control
US5731208A (en) 1996-09-09 1998-03-24 Washington University Method of detecting conditions indicative of atherosclerosis

Also Published As

Publication number Publication date
US20040185514A1 (en) 2004-09-23
US20040185515A1 (en) 2004-09-23
US7662577B2 (en) 2010-02-16
US6780605B1 (en) 2004-08-24
US20040185516A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
SE9802402D0 (sv) Method of diagnosing cardiovascular disease and early atherosclerosis
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
DE69836272D1 (de) Versuchsanordnung zur bestimmung von analyten in körperflüssigkeiten
MX9601324A (es) Biosensor.
DE69603491D1 (de) Reagenz und verfahren zur differentiellen bestimmung von leukocyten im blut
ES2061422T3 (es) Metodos para detectar la resorcion osea in vivo.
DE69618447T2 (de) Frühzeitiger nachweis von prostatakrebs (cap) durch bestimmung des konzentrationsverhältnisses zwischen prostataspezifischem antigen (psa) und menschlichem drüsenkallikrein (hgk-1)
AU4948999A (en) Method of diagnosing cardiovascular disease and early atherosclerosis
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
ATE258310T1 (de) Testverfahren für collagenpeptid
ES2142070T3 (es) Utilizacion de un complejo ficobiliproteina-peptido de enlace como trazador fluorescente.
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
IT1241154B (it) Metodo e composizione reagente per la determinazione dell'alanina amminotrasferasi e dell'antigene hbsag in uno stesso campione biologico
IT8921788A0 (it) Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici.
DK0791073T3 (da) Analysemetode
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
DE69426028D1 (de) Reagenz für die enzymatische Bestimmung des Bikarbonatgehalts in Blutserum
ATE223055T1 (de) Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
DE60212998D1 (de) Gesamtcystein-assay
DE59609166D1 (de) Bestimmung der endständigen sialinsäurereste des human-transferrin-moleküls
DE69833546D1 (de) Verfahren zur bestimmung des procarboxypetidase-a- und carboxypeptidase-a-spiegels in biologischen flüssigkeiten
DE69531059D1 (de) Antikörperreagens zum aufspüren des aneurysma dissecans der aorta sowie dessen verwendung
BR9507228A (pt) Processo para detectar a presença de um analito em uma amostra de um fluido corpóreo soluçao tampao para o tratamento de uma amostra de fluido corpóreo a ser ensaiada e kit